PA Advocacy Day has been cancelled due to the Coronavirus (COVID-19). There are still ways you can make an impact that include writing letters and making phone calls to your legislators.
- Write Letters to your Legislators –Click here to download a sample letter to send to your legislator. Be sure to customize your letter to include the HTC you are treated at and include personal stories why funding for the Hemophilia Treatment Centers is important to you.
- Make Phone Calls – Download phone call tips and a sample script here. Don’t hesitate to reach out to us at the Foundation at 484-445-4282 if you would like to practice a call or go over talking points before your call.
THIS IS OUR LOCAL ISSUE
The Specialty Care Programs funds have been distributed in previous years through a state procurement process known as a Sole Source request. This ensured that if the hemophilia line item was in the state budget, all 7 hemophilia treatment centers in Pennsylvania received state funding. This will end on June 30, 2020. In its place is a new grant process called Request for Applications (RFAs). The RFAs will use a regional approach, based the on the Pennsylvania HealthChoices five regions. Problems with this model include:
- There are 7 federally supported hemophilia treatment centers (HTCs) but only 5 HealthChoices regions, with 4 HTCs located in Philadelphia.
- While applicants may apply for multiple regions, having only one grant awarded per region is problematic when four world class HTCs are in one region (Philadelphia). As proposed, the four HTCs in Philadelphia will be pitted against each other competing for funding.
- When we voiced this concern in the meeting with the Department of Health they told us they expect the Treatment Centers to team up to apply for funding. But this only creates more problems as to who will be responsible for the administrative burden and how will the funding be divided between them?
This one-size fits all approach that the Department of Health is requiring for all specialty care programs clearly doesn’t work for hemophilia and will only jeopardize our HTCs funding. Lost funding can result in staff positions being eliminated, which will result in loss of comprehensive care.
We are asking the General Assembly to keep the Hemophilia Program as a separate line item at the current fiscal year amount of $959,000. In addition, we request that the funding continue to be distributed, as in previous years, to all seven hemophilia treatment centers in Pennsylvania. Here are more resources that you can download on our site:
Be sure to let us know the results of your call and if you sent a letter. Provide us with as many details as possible. Please email or call us at 484-445-4282.
Our primary concern is, and has always been, the health and wellness of the people and community we serve. We appreciate your understanding during a very dynamic situation. We will be in touch in the coming months with updates on when we can start to schedule home office visits with legislators.